Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Ulrich Heininger. (2010) Update on pertussis in children. Expert Review of Anti-infective Therapy 8:2, pages 163-173.
Read now
Read now
Articles from other publishers (34)
Danyal Imani, Tannaz Bahadori, Sedighe Ghourchian, Forough Golsaz-Shirazi, Masoumeh Douraghi, Mahmood Jeddi-Tehrani, Mohammad Mehdi Amiri & Fazel Shokri. (2023) Novel mouse monoclonal antibodies against Bordetella pertussis pertactin antigen with versatile applications. Journal of Microbiological Methods 211, pages 106786.
Crossref
Crossref
Ulrich Heininger. 2021. Pediatric Vaccines and Vaccinations. Pediatric Vaccines and Vaccinations
185
194
.
N. P. Mamchik, N. V. Gabbasova, T. N. Sitnik & L. V. Steinke. (2020) Pertussis in the Voronezh Region: Epidemiology and Vaccination. Epidemiology and Vaccinal Prevention 19:2, pages 79-86.
Crossref
Crossref
Ulrich Heininger. 2017. Pediatric Vaccines and Vaccinations. Pediatric Vaccines and Vaccinations
161
169
.
U. Heininger. (2016) PertussisPertussis. Monatsschrift Kinderheilkunde 164:11, pages 987-993.
Crossref
Crossref
Lale Ozisik, Mine Durusu Tanriover, Shirley Rigby & Serhat Unal. (2016) ADVICE for a healthier life: Adult Vaccination Campaign in Europe. European Journal of Internal Medicine 33, pages 14-20.
Crossref
Crossref
Delma J. Nieves & Ulrich Heininger. 2016. Emerging Infections 10. Emerging Infections 10
311
339
.
Delma J. Nieves & Ulrich Heininger. (2016)
Bordetella pertussis
. Microbiology Spectrum 4:3.
Crossref
Crossref
M. Garbiras, A. Shabaka, N. Calvo, L. Martin, M.A. Moreno, V. Lopez de la Manzanara & A.I. Sanchez-Fructuoso. (2016) Whooping cough in a renal transplant recipient. Transplant Infectious Disease 18:2, pages 280-283.
Crossref
Crossref
Nihal M. Ibrahim, Ebtsam M. El-kady, Somiaa A. Eissa & Ahmed F. Wahby. (2016) Assessment of antibody level and avidity against Bordetella pertussis in a cohort of Egyptian individuals aged 1–18 years. Journal of Advanced Research 7:1, pages 105-111.
Crossref
Crossref
Ulrich Heininger. (2015) The persistence of pertussis and developments in vaccination strategies. The Lancet Respiratory Medicine 3:9, pages 668-670.
Crossref
Crossref
R.M. Carlsson, L. Gustafsson, H.O. Hallander, M. Ljungman, P. Olin, L. Gothefors, L. Nilsson & E. Netterlid. (2015) Two consecutive randomized controlled pertussis booster trials in children initially vaccinated in infancy with an acellular vaccine: The first with a five-component Tdap vaccine to 5-year olds and the second with five- or monocomponent Tdap vaccines at age 14–15 years. Vaccine 33:31, pages 3717-3725.
Crossref
Crossref
Rubén Solano, Cristina Rius, Pere Simón, Sandra Manzanares-Laya, Miriam Ros, Diana Toledo, Àngela Domíngez & Joan A. Caylà. (2014) Evaluation of reported cases of pertussis: epidemiological study in a large city in Spain. Journal of Medical Microbiology 63:12, pages 1688-1695.
Crossref
Crossref
U. Heininger. (2014) Vaccination of health care workers against pertussis: Meeting the need for safety within hospitals. Vaccine 32:38, pages 4840-4843.
Crossref
Crossref
C. CONDE-GLEZ, E. LAZCANO-PONCE, R. ROJAS, R. DeANTONIO, L. ROMANO-MAZZOTTI, Y. CERVANTES & E. ORTEGA-BARRÍA. (2013)
Seroprevalence of
Bordetella pertussis
in the Mexican population: a cross-sectional study
. Epidemiology and Infection 142:4, pages 706-713.
Crossref
Crossref
Young Ik HanJi Yeon ChoiHyewon LeeTeak-jin Lee. (2014) Active Surveillance of Pertussis in Infants Under 6 Months of Age: A Single Center Experience from 2011 to 2013. Korean Journal of Pediatric Infectious Diseases 21:2, pages 114.
Crossref
Crossref
I. Crespo & À. Domínguez. (2013) Tos ferina: cambios en la epidemiología. España 2000-2011. Vacunas 14:4, pages 155-161.
Crossref
Crossref
Birgit Thierry-Carstensen, Tine Dalby, Michael A. Stevner, John B. Robbins, Rachel Schneerson & Birger Trollfors. (2013) Experience with monocomponent acellular pertussis combination vaccines for infants, children, adolescents and adults—A review of safety, immunogenicity, efficacy and effectiveness studies and 15 years of field experience. Vaccine 31:45, pages 5178-5191.
Crossref
Crossref
Magda Campins, David Moreno-Pérez, Angel Gil-de Miguel, Fernando González-Romo, Fernando A. Moraga-Llop, Javier Arístegui-Fernández, Anna Goncé-Mellgren, José M. Bayas & Lluís Salleras-Sanmartí. (2013) Tos ferina en España. Situación epidemiológica y estrategias de prevención y control. Recomendaciones del Grupo de Trabajo de Tos ferina. Enfermedades Infecciosas y Microbiología Clínica 31:4, pages 240-253.
Crossref
Crossref
M. Prelog, G. Almanzar, N. Rieber, B. Ottensmeier, M. Zlamy & J. Liese. (2013) Differences of IgG antibody avidity after an acellular pertussis (aP) booster in adolescents after a whole cell (wcP) or aP primary vaccination. Vaccine 31:2, pages 387-393.
Crossref
Crossref
. 2013. Ferri's Clinical Advisor 2013. Ferri's Clinical Advisor 2013
784
929
.
Angela Bechini, Emilia Tiscione, Sara Boccalini, Miriam Levi & Paolo Bonanni. (2012) Acellular pertussis vaccine use in risk groups (adolescents, pregnant women, newborns and health care workers): A review of evidences and recommendations. Vaccine 30:35, pages 5179-5190.
Crossref
Crossref
Phung Lang, Hanspeter Zimmermann, Ursula Piller, Robert Steffen & Christoph Hatz. (2011) The Swiss National Vaccination Coverage Survey, 2005–2007. Public Health Reports 126:2_suppl, pages 97-108.
Crossref
Crossref
Monica N. Wymann, Jean-Luc Richard, Beatriz Vidondo & Ulrich Heininger. (2011) Prospective pertussis surveillance in Switzerland, 1991–2006. Vaccine 29:11, pages 2058-2065.
Crossref
Crossref
Nicole Guiso, Carl-Heinz Wirsing von König, Kevin Forsyth, Tina Tan & Stanley A. Plotkin. (2011) The Global Pertussis Initiative: Report from a Round Table Meeting to discuss the epidemiology and detection of pertussis, Paris, France, 11–12 January 2010. Vaccine 29:6, pages 1115-1121.
Crossref
Crossref
Peter McIntyre & Nicholas Wood. (2009) Pertussis in early infancy: disease burden and preventive strategies. Current Opinion in Infectious Diseases 22:3, pages 215-223.
Crossref
Crossref
John B. Robbins, Rachel Schneerson, Jerry M. Keith, Mark A. Miller, Joanna Kubler-Kielb & Birger Trollfors. (2009) Pertussis Vaccine. Pediatric Infectious Disease Journal 28:3, pages 237-241.
Crossref
Crossref
Mark Blatter, Leonard R. Friedland, Wayde M. Weston, Ping Li & Barbara Howe. (2009) Immunogenicity and safety of a tetanus toxoid, reduced diphtheria toxoid and three-component acellular pertussis vaccine in adults 19–64 years of age. Vaccine 27:5, pages 765-772.
Crossref
Crossref
Laurene Mascola & David E. Dassey. 2009. Feigin and Cherry's Textbook of Pediatric Infectious Diseases. Feigin and Cherry's Textbook of Pediatric Infectious Diseases
3447
3480
.
James D. Cherry & Ulrich Heininger. 2009. Feigin and Cherry's Textbook of Pediatric Infectious Diseases. Feigin and Cherry's Textbook of Pediatric Infectious Diseases
1683
1706
.
Sandra Crameri & Ulrich Heininger. (2008) Successful control of a pertussis outbreak in a university children's hospital. International Journal of Infectious Diseases 12:6, pages e85-e87.
Crossref
Crossref
Nicholas Wood & Peter McIntyre. (2008) Pertussis: review of epidemiology, diagnosis, management and prevention. Paediatric Respiratory Reviews 9:3, pages 201-212.
Crossref
Crossref
Kevin D. Forsyth, Carl-Heinz Wirsing von Konig, Tina Tan, Jaime Caro & Stanley Plotkin. (2007) Prevention of pertussis: Recommendations derived from the second Global Pertussis Initiative roundtable meeting. Vaccine 25:14, pages 2634-2642.
Crossref
Crossref
L. Salleras, J.M. Bayas, F. Calbo, M. Campins, J. Castrodeza, A. Cerrillo, M. Conde, A. Domínguez, V. Domínguez, J.A. Forcada, A. Gil, J.R. de Juanes & M.C. Saenz. (2007) Vacunación anti-tos ferina de los adolescentes y adultos. Puesta al día. Vacunas 8:1, pages 38-47.
Crossref
Crossref